Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00592-014-0562-6.pdf
Reference56 articles.
1. Perseghin G, Calori G, Lattuada G, Ragogna F, Dugnani E, Garancini MP, Crosignani P, Villa M, Bosi E, Ruotolo G, Piemonti L (2012) Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up. Acta Diabetol 49:421–428
2. Yang X, So WY, Ma RC, Kong AP, Lee HM, Xu G, Ozaki R, Chan JC (2012) Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Acta Diabetol 49(Suppl 1):S185–S193
3. Zhang F, Yang Y, Skrip L, Hu D, Wang Y, Wong C, Qiu J, Lei H (2012) Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case–control and 25 cohort studies. Acta Diabetol 49(Suppl 1):S235–S246
4. Onishi S, Takemoto M, Ishikawa T, Okabe E, Ishibashi R, He P, Kobayashi K, Fujimoto M, Kawamura H, Yokote K (2012) Japanese diabetic patients with Werner syndrome exhibit high incidence of cancer. Acta Diabetol 49(Suppl 1):S259–S260
5. Lauper JM, Monnat RJ Jr. (2013) Diabetes mellitus and cancer in Werner syndrome. Acta Diabetol. doi: 10.1007/s00592-013-0456-z
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Knowledge mapping of metformin use on cancers: a bibliometric analysis (2013–2023);Frontiers in Pharmacology;2024-08-13
2. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients;Frontiers in Endocrinology;2023-07-25
3. The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin;Pharmaceuticals;2023-02-01
4. Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study;Otolaryngology–Head and Neck Surgery;2023-01-27
5. The relationship between metformin consumption and cancer risk: An updated umbrella review of systematic reviews and meta-analyses;International Journal of Preventive Medicine;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3